Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Omnipod Pod Recall; Afrezza OK'd for Kids 6 and Up; CVS to Cover Zepbound Again

The recall covers about 7 million pods after reports of insulin under-delivery and 24 serious adverse events, including hospitalizations and diabetic ketoacidosis.

Summary by MedPage Today
(MedPage Today) -- Insulet initiated a voluntary device correction of certain Omnipod pods due to a manufacturing defect that causes insulin to leak rather than being fully delivered into the body, the FDA alerted. This action is separate from...

2 Articles

MedPage TodayMedPage Today
Center

Omnipod Pod Recall; Afrezza OK'd for Kids 6 and Up; CVS to Cover Zepbound Again

(MedPage Today) -- Insulet initiated a voluntary device correction of certain Omnipod pods due to a manufacturing defect that causes insulin to leak rather than being fully delivered into the body, the FDA alerted. This action is separate from...

·New York, United States
Read Full Article
PreventionPrevention
Center

7 Million Insulin Pumps Recalled Over Dangerous Defect, FDA Warns

Millions of Omnipod insulin pumps are being recalled over a dangerous manufacturing issue, according to the FDA. Here's what you need to know.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Prevention broke the news on Monday, June 1, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

FDA icon

FDA

CVS icon

CVS

United States icon

United States

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal